Hepatic Disorders: Hepatitis/CirrhosisRNSG
Hepatitis B: may prevent hepatitisB,cirrhosisandliver cancer shanghai.ufh.com.cn shanghai.ufh.com.cn 乙肝疫苗:也许可以预防乙肝、肝硬化和肝癌 shanghai.ufh.com.cn shanghai.ufh.com.cn This is the most common genetic liver disorder in children ...
The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma. J. Cell. Mol. Med. 21, 986–992 (2017). Article PubMed Central PubMed Google Scholar Thietart, S. & Rautou, P.-E. Extracellular vesicles as biomarkers in liver diseases: a clinician’s point of view. J...
27Malhotra A, Naniwadekar A, Sood G. Hepatobiliary and pancreatic: Cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol 2008;23:1942 28Gupta S, Faughnan ME, Prud'homme GJ, Hwang DM, Munoz DG, Kopplin P. Sarcoidosis complicated by cirrhosis and hepatopulmonary syndrome. Can Respir ...
Therefore, the noninvasive criteria could be probably applied to the HCC cases without cirrhosis, especially in patients with chronic hepatitis. There were several limitations in our study. First, the sensitivity and specificity were not calculated. The results of our study need to be validated in...
To study the correlation between the changes of hepatic segmental volumes and the severity of hepatitis B cirrhosis, classified by Child-Pugh score.The study cohort comprised viral hepatitis B cirrhotic patients with different severity (Child-Pugh score grade A to C) and control subjects who underwe...
MR elastography, a new technique to detect liver stiffness, has not been demonstrated to detect NAFLD, and is still undergoing research in patients with hepatitis and cirrhosis. In conclusion, all these imaging tools are limited in their ability to detect coexisting inflammation and fibrosis. In ...
The aim of this prospective study was to assess the accuracy of liver stiffness measurement for the detection of fibrosis and cirrhosis in HIV/hepatitis C virus (HCV)-coinfected patients and to compare its accuracy with other noninvasive methods. METHODS: We studied 72 consecutive HIV patients ...
Hepatitis B virus causes chronic infections in 250 million people worldwide. Chronic hepatitis B virus carriers are at risk of developing fibrosis, cirrhosis, and hepatocellular carcinoma. A prophylactic vaccine exists and currently available antivirals can suppress but rarely cure chronic infections. The...
[摘要] 目的 研究恩替卡韦长期治疗乙型肝炎相关性肝硬化(乙肝相关肝硬化)患者的疗效和安全性,探讨预后影响因素。方法 120例乙肝相关肝硬化抗病毒初治患者,按1∶1原则随机分为恩替卡韦治疗组60例和拉米夫定对照组60例,进行144周治疗。结果 120例患者在48周内共死